Addressing prostate cancer’s racial disparity starts with you February 9, 2020 Several decades of data show that Black men are less likely to be screened and treated for prostate cancer than their white counterparts. In this interview, Kelvin A. Moses, MD, PhD, discusses the reasons for these disparities, potential genetic, cultural, and environmental factors, new data showing improved outcomes in Black men receiving certain treatments, and how practicing urologists can address prostate cancer disparities. Dr. Moses is associate professor of urology at Vanderbilt University Medical Center, Nashville, TN.Read the full article here. Source: Brantley Thrasher, MD - Urology Times About Prostate Cancer Health Equity Prostate Cancer News More for you
Several decades of data show that Black men are less likely to be screened and treated for prostate cancer than their white counterparts. In this interview, Kelvin A. Moses, MD, PhD, discusses the reasons for these disparities, potential genetic, cultural, and environmental factors, new data showing improved outcomes in Black men receiving certain treatments, and how practicing urologists can address prostate cancer disparities. Dr. Moses is associate professor of urology at Vanderbilt University Medical Center, Nashville, TN.Read the full article here. Source: Brantley Thrasher, MD - Urology Times
Complete the Survey
